EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thorsten Wittwer
Ulrich F.W. Franke
Thorsten Wahlers
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittwer, T.
Right arrow Articles by Wahlers, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittwer, T.
Right arrow Articles by Wahlers, T.
Related Collections
Right arrow Lung - transplantation

Eur J Cardiothorac Surg 2004;26:144-150
© 2004 Elsevier Science NL


Innovative pulmonary preservation of non-heart-beating donor grafts in experimental lung transplantation

Thorsten Wittwera*, Ulrich F.W. Frankea, Antonia Fehrenbachb,c, Matthias Ochsb, Tim Sandhausa, Niels Dreyerb, Joachim Richterb, Thorsten Wahlersa

a Department of Cardiothoracic and Vascular Surgery, Friedrich-Schiller University, Bachstrasse 18, 07740 Jena, Germany
b Department of Electron Microscopy, University of Göttingen, Germany
c Clinical Research Group ‘Chronic Airway Diseases’, Department of Internal Medicine (Respiratory Medicine), Philipps-University Marburg, Marburg, Germany

Received 5 November 2003; received in revised form 19 January 2004; accepted 20 January 2004.

* Corresponding author. Tel.: +49-3641-934-801; fax: +49-3641-934-802
e-mail: th.wittwer-md{at}t-online.de


    Abstract
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Comment
 References
 
Objective: Lung transplantation is limited by scarcity of donor organs. Lung retrieval from non-heart-beating donors (NHBD) might have the potential to extend the donor pool and has been reported recently. However, no studies in NHBD exist using the novel approach of retrograde preservation with Perfadex solution. Methods: Asystolic heparinized pigs (n=5/group) were continuously ventilated for 90, 180 or 300 min of warm ischemia. Lungs were then retrogradely preserved with Perfadex and stored at 4 °C in inflation. After 3 h of additional cold ischemia, left lung transplantation was performed. Hemodynamics, pO2/FiO2 and dynamic compliance were monitored for 5 h. Intrapulmonary lung water was determined by both global wet-to-dry lung weight ratio (W/D ratio) and standard stereological examination of relative volume fractions of intraalveolar edema. All results were compared to sham-operated controls and to lungs obtained from standard heart-beating donors after retrograde preservation with Perfadex and 27 h of cold ischemia. Statistics comprised ANOVA analysis with repeated measures and Mann–Whitney tests. Results: No mortality was observed. During flush preservation of NHBD lungs, continuous elimination of blood clots via the pulmonary artery was observed. Oxygenation, compliance, intraalveolar edema fraction and W/D ratio were comparable between groups, whereas PVR was significantly lower in sham-controls. Conclusions: Use of NHBD lungs is feasible and results in similar postischemic outcome when compared to sham-controls and standard preservation procedures even after 5 h of pre-harvest warm ischemia. Especially, the NHBD with high-risk constellations for intravascular coagulation might benefit from retrograde preservation by elimination of thrombi from the pulmonary circulation. This innovative technique might also be considered in situations, where brain-dead organ donors become hemodynamically unstable prior to onset of organ harvest. Further trials with longer warm and cold ischemic periods are initiated to further elucidate this promising approach of donor pool expansion.

Key Words: Retrograde pulmonoplegia • Non-heart-beating donors • Perfadex lung preservation • Lung transplantation


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Comment
 References
 
Although lung transplantation has been proven to be an effective therapy for patients with end-stage pulmonary disease, access to this therapy is severely limited by the progredient scarcity of suitable donor organs in the last years [1]. Currently, aside from living-related organ donation, all suitable lung grafts are retrieved from brain-dead heart-beating donors. However, it is estimated that 35,000 people in the US are killed from firearms while 47,000 deaths are related to motor vehicle accidents [2]. If just a small portion of these acutely injured people after unsuccessful resuscitation were candidates for non-heart-beating organ donation, this might increase the number of available organs by up to 20–30% [3,4]. Lung retrieval from non-heart-beating donors (NHBD) is considered to be a realistic therapeutic option as the lung is unique among the transplanted solid organs in the way that it is not dependent on vascular perfusion to meet its oxygen needs. Experimentally, pulmonary cells obtained from ventilated cadavers have been cultured successfully, indicating lung parenchymal cell death does not necessarily occur at the time of clinical death [5]. Previous studies in our laboratory have shown that the quality of pulmonary preservation in terms of postischemic lung function can be significantly improved by the innovative technique of retrograde flush perfusion (RFP) via the left atrium into the pulmonary venous system [6]. However, there is no information so far concerning the feasibility of RFP with low-potassium dextran solution with regard to achievable quality of pulmonary preservation when NHBD-lungs with the high risk of microvascular thrombi formation are used for transplantation.

The present detailed study compared RFP in NHBD lungs of variable warm ischemic intervals with standard preservation procedures using heart beating donors and sham controls. The main rationale was to evaluate if the innovative strategy of retrograde preservation of NHBD lungs is feasible and safe in terms of postischemic outcome even with extended and clinically realistic ischemic intervals.


    2. Materials and methods
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Comment
 References
 
2.1. Experimental groups
Female domestic pigs weighing from 28 to 32 kg were randomized into five groups of five animals each. One group served as a sham-operated control group (group 5) and was prone to surgical dissection of hilar structures, but neither organ preservation nor transplantation was performed. In the remaining groups, either NHBD lungs were preserved for 3 h of cold ischemia time (CIT) by RFP with LPD solution (Perfadex; Vitrolife, Göteborg, Sweden) after a variable ventilated warm ischemia time (WIT) of 90 (group 1), 180 (group 2) and 300 min (group 3), respectively, or lungs from standard heart beating donors were retrogradely preserved for 27 h of CIT. In all of these test groups (groups 1–4), five additional animals were used as lung recipients.

2.2. Surgical procedure
2.2.1. Donor preparation
All animals were premedicated with ketamine 10% (20 mg/kg), atropine (0.04 mg/kg) and propofol (3 mg/kg). Pigs were then put in the supine position, intubated and mechanically ventilated with 50% oxygen in a pressure-controlled mode with a peak inspiratory pressure of 20 mmHg, a rate of 18 breaths per minute, an inspiratory/expiratory ratio of 1:1 and a PEEP of 8 mmHg. Anesthesia was continued with infusion of fentanyl (0.3 µg/kg per min), midazolam (20 µg/kg per min) and pancuronium (10 µg/kg per min). All animals received 200 IE/kg of heparin intravenously. A median sternotomy was performed and the pericardium was opened longitudinally. A perfusion cannula with a sideport to measure the perfusion pressure was placed through the auricle into the left atrium. In NHBD lungs (groups 1–3), cardiac fibrillation was induced electrically, and the cadaver was ventilated at an FiO2 of 0.5 and left at room temperature for 90, 180 and 300 min of WIT, respectively. In the standard heart-beating group (group 4), no WIT was applied, and retrograde perfusion via the left atrium was started directly with an incision in the anterior aspect of the main pulmonary artery for drainage of the LPD solution. An 8 min period was required to infuse 1800 ml LPD solution at 4 °C with a maximum flushing pressure of 14 mmHg. Continuous topical cooling of the lungs was not performed in any group in order to specifically assess the impact of retrograde flush preservation. No prostaglandins were used neither in the donor animal nor in the preservation solution as the LPD solution induces significantly less vasoconstriction during flush preservation. Ventilation was continued throughout the entire perfusion period. After completion of the preservation, the heart–lung bloc was excised with both lungs inflated in an endinspiratory state and stored at 4 °C for 3 h.

2.2.2. Recipient/sham-preparation
The anesthetic regimen was identical to the donor procedure. A Swan-Ganz catheter (7.5F, Baxter Healthcare Corp., Irvine, CA, USA) and a catheter to monitor the arterial pressure (Leader Cath 20G 8 cm, Vygon, France) were placed into the right carotid artery and external jugular vein, respectively. All animals were placed in a right decubitus position, and a left thoracotomy was performed in the fifth intercostal space. The pulmonary bifurcation left main bronchus and left pulmonary veins were dissected in all groups. After clamping of the left pulmonary artery and bronchus, the left pulmonary veins were ligated and pneumonectomy was performed in the test groups (groups 1–4) only. The left donor lung was isolated from the heart–lung bloc and prepared for implantation with a large atrial cuff and full length of both the pulmonary artery and left main bronchus. Implantation of the donor lung started with the bronchial anastomosis using a running suture with 4–0 Prolene (Ethicon Inc., Somerville, NJ, USA) followed by the arterial anastomosis with a running suture of 6–0 Prolene. After clamping of the left atrium, a recipient atrial cuff was designed and anastomosed to the donor atrial cuff using a running suture of 5–0 Prolene. Prior to reperfusion, the donor lung was carefully de-aired retrogradely. The pulmonary artery was then unclamped and the graft reventilated in a pressure-controlled mode with a peak inspiratory pressure of 30 mmHg using a PEEP of 10 mmHg with a respiratory rate of 18/min. After 15 min of reperfusion, the contralateral right pulmonary artery and bronchus were clamped both in the sham-operated control group and all test groups. All lungs were reperfused for 5 h followed by termination of the experiment by intravenous injection of magnesium sulfate.

2.3. Functional analysis
In all experiments, arterial and pulmonary artery pressures as well as central venous and left atrial pressures were recorded continuously. Dynamic lung compliance was monitored by the ventilator (Evita 2 dura, Dräger Medical Inc., Lübeck, Germany). An arterial and mixed-venous blood gas analysis was performed initially and in 30 min intervals during the reperfusion period. Cardiac output was measured continuously by the Swan-Ganz catheter, and systemic and pulmonary vascular resistances were calculated.

2.4. Stereological analysis
After completion of the reperfusion period, the entire left lung was further processed for light microscopy by fixation using vascular perfusion via the pulmonary artery with 2 l of a 1.5% paraformaldehyde/glutaraldehyde solution in 0.1 M cacodylate buffer at 15 cmH2O pressure. During this fixation the lung was inflated with a constant pressure of 12 cmH2O. In order to collect lung material, which is representative for the whole lung, systematic random sampling of tissue was performed. Lungs were cut into 10 mm thick slices. A transparent paint grid was then superimposed over the section of slices. Whenever a point hit the surface of the lung slice, a 1 cm3-tissue block was excised. The tissue was dehydrated through a graded series of ethanol and embedded in a methacrylate resin (Technovit 7100, Kulzer, Heraeus, Germany). Sections of 1 µm were cut from each block (10–12 per lung) and stained with methyleneblue/Azur II (1:2). The relative volume fraction of intraalveolar edema formation referred to lung parenchyma was determined by established stereological techniques [7] using a Cast-Grid-System 2.0 (Olympus, Denmark).

2.5. Animal care
All animals received humane care in compliance with the European Convention on Animal Care and with the, ‘Principles of Laboratory Animal Care’, formulated by the National Society for Medical Research and the, ‘Guide for the Care and Use of Laboratory Animals’, prepared by the Institute of Laboratory Animal Resources, National Research Council, and published by the National Academy Press, revised 1996. The study was approved by the institutional ethics committee.

2.6. Statistical analysis
All data are expressed as mean±SD and were analyzed with the Statistical Program of Social Sciences (SPSS for MS Windows, Version 10.0; SPSS Inc., Chicago, IL, USA). Continuous data were analyzed using ANOVA with repeated measures. Statistical significance was assumed with a P-value <0.05.

For evaluation of data without repeated measures, standard analysis of variance was used. Stereological data were analyzed using Mann–Whitney tests. According to the Holm-method (modified by Shaffer), statistical significance for comparison of five groups was assumed with a P-value <0.0083.


    3. Results
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Comment
 References
 
During retrograde flush preservation, a continuous washout of small blood and fibrin clots from the pulmonary arterial venting site was noticed in all test lungs, but the extent of clot formation was quantitatively more pronounced in NHBD lungs.

3.1. Functional analysis
3.1.1. Oxygenation capacity (pO2/FiO2)
All animals survived the entire observation period of 5 h with sufficient pulmonary function. Although sham-operated animals presented with highest oxygenation values (sham 460.91±50.25), there were no statistically significant differences when compared to all NHBD groups (NHBD 90, 386.49±166.89; NHBD 180, 381.38±117.71; NHBD 300, 361.93±118.06) and the standard heart beating group (PER 27h, 412.45±106.67; P=0.665, Fig. 1) .



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1. Oxygenation in terms of pO2/FiO2 of transplanted lungs of domestic pigs during the observation period of 5 h following exclusion of the native right lung. Differences are not statistically significant (P=0.665).

 
3.1.2. Pulmonary vascular resistance [PVR (dyn s cm–5)]
At early reperfusion and ligation of the contralateral lung, a significant but comparable increase of pulmonary vascular resistance was calculated in all test groups (NHBD 90, 925.72±275.57; NHBD 180, 997.06±74.97; NHBD 300, 1004.11±334.01; PER 27h, 1130.5±251.87), while the corresponding values in the sham-control group were found to be significantly lower during the observation period (sham 535.82±237.2; P<0.04; Fig. 2) . However, no significant differences were obtained between NHBD grafts and lungs from heart beating donors (P>0.25).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2. Pulmonary vascular resistance (PVR) of transplanted lungs of domestic pigs during the observation period of 5 h following exclusion of the native right lung. Differences between sham-grafts and all test lungs are statistically significant (P<0.04).

 
3.1.3. Dynamic lung compliance (ml/mbar)
The dynamic lung compliance over 5 h of reperfusion was found to be reduced after clamping of the contralateral bronchus but remained comparable between all groups (NHBD 90, 11.73±5.05; NHBD 180, 11.48±1.95; NHBD 300, 14.78±3.64; PER 27h, 14.2±8.61; sham 12.34±1.07; P>0.34, Fig. 3) .



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3. Dynamic lung compliance of transplanted lungs of domestic pigs during the observation period of 5 h following exclusion of the native right lung. Differences are not statistically significant (P>0.34).

 
3.1.4. Wet-to-dry-ratio (W/D)
Although the lowest ratio was found to be in sham-lungs (6.02±0.77), W/D ratios were generally comparable in between groups (NHBD 90, 7.3±0.71; NHBD 180, 6.69±0.58; NHBD 300, 6.29±0.64; PER 27h, 6.8±0.74; P=0.134; Fig. 4) .



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4. Wet-to-dry lung weight ratio (W/D) of transplanted lungs of domestic pigs after the observation period of 5 h following exclusion of the native right lung. Differences are not statistically significant (P=0.134).

 
3.2. Histology
Stereological analysis revealed the lowest volume fraction of intraalveolar edema referred to lung parenchyma in sham-control lungs (1.74±0.35%, Fig. 5) . However, neither preservation of lungs from standard brain dead donors (PER 27h, 5.16±4.64%) nor use of grafts from any NHBD group (NHBD 90, 8.04±6.24% [Fig. 6] ; NHBD 180, 4.7±2.72%; NHBD 300, 4.27±0.75%) resulted in statistically significantly different volume fractions of intraalveolar edema (Fig. 7) .



View larger version (148K):
[in this window]
[in a new window]
 
Fig. 5. Parenchyma of a sham-control animal 5 h after reperfusion without any intrapulmonary edema formation. Du, ductus alveolaris.

 


View larger version (179K):
[in this window]
[in a new window]
 
Fig. 6. Moderate formation of intraalveolar edema (Ed) after 5 h of reperfusion in a non-heart-beating donor lung with 90 min of warm ischemia (NHBD 90).

 


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 7. Comparison of volume fractions of intraalveolar edema referred to lung parenchyma in domestic pig lungs after 4 h of observation. Differences are not statistically significant (P>0.0083).

 

    4. Comment
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Comment
 References
 
Currently, lung transplantation offers a realistic therapeutic option and has become an effective method for patients with end stage parenchymal or vascular pulmonary disease. Compared to initial results, the improved outcome is mainly related to optimised immunosuppression regimens and modified protocols for pulmonary preservation. However, early graft dysfunction is still a continuing problem resulting from a multifactorial lung injury starting within the donor and continuing during harvesting, organ storage, implantation and postischemic reperfusion. Furthermore, the number of suitable donor lungs among the current pool of multiple organ donors is just about 20% [8] and is, therefore, insufficient to meet the rapidly growing demand for lung grafts. Although there has been a trend towards utilisation of the so-called ‘marginal’ donor lungs with satisfying results [9], there is still a progredient discrepancy between patients on the waiting list and the availability of suitable donor organs. Organs from NHBD, which have been used clinically in renal transplantation, might represent an important organ alternative source for a significant increase of the available donor pool [4]. The lung is unique among the vital organs owing to its remarkable tolerance to warm ischemia which is premised on the fact that pulmonary parenchymal cells are able to maintain aerobic metabolism with the alveolar oxygen even after cessation of vascular circulation [5]. In the last years, several authors have investigated the tolerance of ventilated lung grafts to different periods of warm ischemia with overall promising results [10,11]. However, although the pulmonary vascular endothelium is considered to maintain its function over several hours of warm ischemia [12], diffuse microvascular thrombosis in the pulmonary circulation is considered to represent a serious and clinically limitating problem encountered with the use of NHBD grafts [13].

Recently, the innovative approach of retrograde preservation of lung grafts has been shown to be very effective in the elimination of different kinds of thrombi from the pulmonary vasculature; macroscopic blood clots and other tissue emboli which are often seen in organ donors with major trauma and multiple bone fractures and which may both alter the uniformity of standard antegrade flushing and severely impair graft reperfusion, can easily be washed out via the pulmonary artery venting site [1416]. Furthermore, the overall quality of organ preservation in terms of postischemic lung function was significantly improved following retrograde lung preservation [6,16,17]. This phenomenon is believed to be due to the more homogeneous distribution in the low-pressure high-capacity pulmonary venous system [18] and the concomitant preservation of the small but important bronchial circulation [19]. However, most of these reports used high-potassium solutions for lung preservation. Since there is clear evidence in the past that use of the modern low-potassium dextran containing Perfadex solution ameliorates reperfusion injury and improves primary graft function in lung transplantation [20] we thought to evaluate if retrograde preservation of NHBD lungs with Perfadex solution is technically feasible and results in sufficient preservation quality in terms of pulmonary function even after extended periods of ventilated warm ischemia.

In our series, we found a postischemic NHBD lung function in terms of oxygenation and lung compliance which was not different from the results obtained with both sham-operated controls and conventional heart beating organ donors with cold ischemia of 27 h. Stereological evaluation revealed a moderate degree of intraalveolar edema formation in NHBD grafts which, however, did not differ significantly from the sham-group. This edema formation correlates with the overall increased pulmonary vascular resistance in all test lungs and represents a mild form of ischemia/reperfusion injury.

Grossly, the functional and histological results obtained with retrogradely preserved NHBD lung allografts did not differ from the general outcome in both sham-operated controls and conventional heart beating organ donors, which further illustrates the excellent preservation properties of this innovative approach.

Of special clinical importance and one of the main results of the presented work is the finding of continuous washout of small blood and fibrin clots from the pulmonary arterial venting site during retrograde preservation in both the standard heart-beating group but especially in NHBD lungs which is also reported by others [1416]. This phenomenon underlines that even with intravenous heparinisation of NHBD as it is recommended by some groups [21], the pulmonary circulation is still prone to some degree of microvascular thrombosis which can alter the postoperative outcome following lung transplantation. However, there are some authors indicating that heparin is not mandatory at all in NHBD [12,22]. Especially in those non-heparinized NHBD lungs the innovative retrograde preservation strategy might display a special benefit in elimination of potential microvascular thrombi and debris.

Clinically, a high proportion of multi-organ donors, especially polytrauma patients, was found to have undetected multiple pulmonary emboli consisting of fat, brain or bone tissue at the time of postmortem examination [2224]. Therefore, in clinical lung transplantation, it seems possible that the high percentage of postischemic primary graft failure in terms of ischemia/reperfusion injury might be at least in part due to undetected preexisting multiple emboli in the donor pulmonary circulation which are not to be mobilized by standard antegrade preservation techniques. Hypothetically, a significant improvement of postoperative graft function especially in NHBD lung transplantation with the described even higher risk of intravascular thrombus formation might, therefore, be expected just due to this single mechanism of embolus evacuation at the time of organ harvest with subsequent adequate preservation of the previously occluded pulmonary segments [22].

A limitation of this pilot study is the still rather short duration of warm ischemia with up to 5 h. However, it is generally agreed that for the clinical use of NHBD lungs, the period of warm ischemia should be kept as short as possible [22]. Furthermore, in accordance with the reported outcome of short-term warm ischemia in our experiments, this novel technique might also be considered in the situation, where an accepted brain-dead organ donor becomes hemodynamically unstable on the intensive care unit or in the operating room prior to onset of organ retrieval. In those not uncommon cases, a time period of 5 h should be enough to harvest at least the continuously ventilated lungs.

Overall, these promising results strongly encourage further multicenter studies in the field of retrograde preservation using NHBD lungs with extended periods of warm and cold ischemia. A potential future use of this innovative preservation strategy might represent a highly relevant tool in the clinical arena to significantly expand the progressively limited pool of donor lungs [25].


    Acknowledgments
 
The writers gratefully acknowledge the expert technical assistance of S. Kirste, K. Hornung, S. Böhm, A. Apel, S. Freese, A. Gerken, H. Hühn and M. Kirste. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, Wa 738/4-1 and Ri 790/2-1).


    Footnotes
 
Presented at the joint 17th Annual Meeting of the European Association for Cardio-thoracic Surgery and the 11th Annual Meeting of the European Society of Thoracic Surgeons, Vienna, Austria, October 12–15, 2003.


    References
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Comment
 References
 

  1. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The registry of the international society for heart and lung transplantation: eighteenth official report—2001. J Heart Lung Transplant 2001;20:805-815.[CrossRef][Medline]
  2. McGinnis J.M., Foege W.H. Actual causes of death in the United States. J Am Med Assoc 1993;270:2207-2212.[Abstract/Free Full Text]
  3. Boglione M.M., Morandini M.A., Barrenechea M.E., Rubio R.A., Aguilar D. Pre-arrest heparinization and ventilation during warm ischemia preserves lung function in non-heart-beating donors. J Pediatr Surg 1999;34:1805-1809.[Medline]
  4. D'Alessandro A.M., Hoffmann R.M., Knechtle S.J., Eckhoff D.E., Love R.B., Kalayoglu M., Sollinger H.W., Belzer F.O. Successful extrarenal transplantation from non-heart-beating donors. Transplantation 1995;59:977-982.[Medline]
  5. D'Armini A.M., Roberts C.S., Griffith P.K., Lemasters J.J., Egan T.M. When does the lung die? I: histochemical evidence of pulmonary viability after death. J Heart Lung Transplant 1994;13:741-747.[Medline]
  6. Wittwer T., Fehrenbach A., Meyer D., Brandes H., Albes J., Richter J., Wahlers T. Retrograde flush perfusion with low-potassium solutions for improvement of experimental pulmonary preservation. J Heart Lung Transplant 2000;19:976-983.[CrossRef][Medline]
  7. Fehrenbach A., Ochs M., Wittwer T., Cornelius J.F., Fehrenbach H., Wahlers T., Richter J. Stereological estimation of the volume weighted mean volumes of alveoli and acinar pathways in the rat lung to describe alterations of the gas-exchange regions after ischemia/reperfusion. J Anatomy 1999;194:127-135.[CrossRef][Medline]
  8. Egan T.M. Non-heart-beating donor: yes or no?. Ann Thorac Surg 2000;70:1451-1452.[Free Full Text]
  9. Sundaresan S., Semenkovich J., Ochoa L., Richardson G., Trulock E.P., Cooper J.D., Patterson G.A. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995;109:1075-1080.[Abstract/Free Full Text]
  10. Shennib H., Kuang J.Q., Giaid A. Successful retrieval and function of lungs from non-heart-beating donors. Ann Thorac Surg 2001;71:458-461.[Abstract/Free Full Text]
  11. Steen S., Ingemannsson R., Budrikis A., Bolys R., Roscher R., Sjöberg T. Successful transplantation of lungs topically cooled in the non-heart-beating donor for 6 hours. Ann Thorac Surg 1997;63:345-351.[Abstract/Free Full Text]
  12. Steen S., Sjöberg T., Pierre L., Liao Q., Eriksson L., Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 2001;357:825-829.[CrossRef][Medline]
  13. Mauney M., Cope J., Binns O. Non-heart-beating donors: a model of thoracic allograft injury. Ann Thorac Surg 1996;62:54-62.[Abstract/Free Full Text]
  14. Alvarez A., Salvatierra A., Algar J., Cerezo F., Santos F., Robles J.C., Baamonde C., Pujol J.L. Preservation with a retrograde second flushing of eurocollins in clinical lung transplantation. Transplant Proc 1999;31:1088-1090.[CrossRef][Medline]
  15. Varela A., Cordoba M., Serrano-Fiz S., Burgos R., Montero C.G., Tellez G., Novoa N., Castedo E., Tebar E., Tellez J., Roda J., Ugarte J. Early lung allograft function after retrograde and antegrade preservation. J Thorac Cardiovasc Surg 1997;114:1119-1120.[Free Full Text]
  16. Venuta F., Rendina E.A., Bufi M., Della Rocca G., Giacomo T.D., Costa M.G., Pugliese F., Coccia C., Ciccone A.M., Coloni G.F. Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovasc Surg 1999;118:107-114.[Abstract/Free Full Text]
  17. Chen C.Z., Gallagher R.C., Ardery P., Dyckman W., Low H.B.C. Retrograde versus antegrade flush in canine left lung preservation for six hours. J Heart Lung Transplant 1996;15:395-403.[Medline]
  18. Sanchez de Leon R., Orchard C.H., Chakrabarti M.K., Sykes M.K. Effect of hypoxia on fluid filtration rate during forward and reverse perfusion of isolated rabbit lungs. Cardiovasc Res 1982;16:711-715.[Medline]
  19. Varela A., Montero C.G., Cordoba M., Antequera A., Perez M., Tabuenca M.J., Berrocal J.O., Tendillo F.J., Mascias A., Santos M., Castillo Olivares J.L. Improved distribution of pulmonary flush solutions to the tracheobronchial wall in pulmonary transplantation. Eur Surg Res 1997;29:1-4.[Medline]
  20. Fischer S., Matte-Martyn A., dePerrot M., Waddell T.K., Sekine Y., Hutcheon M., Keshavjee S. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001;120:594-596.
  21. Kiser A.C., Ciriaco P., Hoffmann S.C., Egan T.M. Lung retrieval from non-heart beating cadavers with use of a rat lung transplant model. J Thorac Cardiovasc Surg 2001;122:18-23.[Abstract/Free Full Text]
  22. Luh S.P., Tsai C.C., Shau W.Y., Chen J.S., Kuo S.H., Shiau S.Y., Lee Y.C. The effects of inhaled nitric oxide, gabexate mesilate, and retrograde flush in the lung graft from non-heart beating minipig donors. Transplantation 2000;69:2019-2027.[CrossRef][Medline]
  23. Rosendale B.E., Keenan R.J., Duncan S.R., Hardesty R.L., Armitage J.A., Griffith B.P., Yousem S.A. Donor cerebral emboli as a cause of acute graft dysfunction in lung transplantation. J Heart Lung Transplant 1992;11:72-76.[Medline]
  24. Waller D.A., Bennett M.K., Corris P.A., Dark J.H. Donor-acquired fat embolism causing primary organ failure after lung transplantation. Ann Thorac Surg 1995;59:1565-1566.[Abstract/Free Full Text]
  25. Novick R.J. Innovative techniques to enhance lung preservation. J Thorac Cardiovasc Surg 2002;123:3-5.[Free Full Text]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Van De Wauwer, A. P. Neyrinck, N. Geudens, F. R. Rega, G. M. Verleden, E. Verbeken, T. E. Lerut, and D. E.M. Van Raemdonck
Retrograde flush following topical cooling is superior to preserve the non-heart-beating donor lung
Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1125 - 1133.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thorsten Wittwer
Ulrich F.W. Franke
Thorsten Wahlers
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittwer, T.
Right arrow Articles by Wahlers, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittwer, T.
Right arrow Articles by Wahlers, T.
Related Collections
Right arrow Lung - transplantation


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS